The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S. अप्रैल 05, 2022 byप्रगतिवादी मंच एक टिप्पणी भेजें Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2. source https://www.nytimes.com/2022/04/05/health/fda-glaxo-antibody-us.html
एक टिप्पणी भेजें
एक टिप्पणी भेजें